AB063. Potential synergistic effect by combination of PED-4 and PED-5 inhibitors plus theophylline in lung cancer?

BACKGROUND: Lung cancer remains the leading cause of cancer-related deaths worldwide and novel therapeutic approaches targeting crucial pathways are urgently needed to improve its treatment. Differentiation-based therapeutics (Methylxanthines) and phosphodiesterase inhibitors (type 4 and 5), have be...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Ann Transl Med
Huvudupphovsmän: Domvri, Kalliopi, Hohenforst-Schmidt, Wolfgang, Zogas, Nikolaos, Petanidis, Savvas, Zarogoulidis, Paul, Porpodis, Konstantinos, Kioseoglou, Efi, Zarogoulidis, Konstantinos
Materialtyp: Artigo
Språk:Inglês
Publicerad: AME Publishing Company 2016
Ämnen:
Abstract
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5159351/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.AB063
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk